The evolving landscape of respiratory viral vaccine development
Submit your research to Expert Review of Vaccines
About the Article Collection
Expert Review of Vaccines is pleased to invite you to the upcoming Article Collection “The evolving landscape of respiratory viral vaccine development.”
As respiratory viral infections continue to pose significant global health challenges, the need for effective vaccines has never been more pressing. Seasonal and pandemic influenza, alongside more recent threats such as COVID-19 and RSV, continue to strain healthcare systems and drive substantial morbidity and mortality worldwide. Vaccine research has therefore become a critical focus for scientists, healthcare professionals, and policymakers alike, and substantial progress has been made in our understanding of immune responses to respiratory viruses, and developing more precise vaccine platforms.
New technologies, such as mRNA-based platforms, have been groundbreaking in their ability to rapidly produce vaccines and demonstrate a high level of efficacy, even in the face of emerging viral variants. These advancements, pivotal in the fight against the recent COVID-19 pandemic, now pave the way for the next generation of respiratory viral vaccines. Beyond influenza and coronaviruses, viruses such as human metapneumovirus (hMPV) and human parainfluenza viruses (hPIVs) contribute significantly to the global burden of respiratory disease and are gaining attention as important vaccine targets.
This Article Collection will explore the latest trends and breakthroughs in respiratory viral vaccine development, including novel platforms, delivery systems, and strategies to address emerging viral variants. The Collection will also focus on the role of vaccines in protecting vulnerable groups such as infants and older adults, who remain at a heightened risk of severe respiratory infections.
Topics of interest include, but are not limited to:
Novel vaccine platforms (e.g. mRNA, viral vectors, protein subunits, intranasal delivery)
Adjuvants and delivery systems tailored for respiratory mucosa
Mucosal and systemic immune responses to respiratory vaccines
Cross-protective and universal vaccine strategies for influenza, RSV, coronaviruses and beyond
Vaccine development for other respiratory pathogens such as hMPV and hPIVs
Interactions between viruses, bacteria and the microbiome/virome that could influence vaccine effectiveness or direct strategies for immunisation
Clinical evaluation, human challenge models, and real-world effectiveness
EVaccination strategies for vulnerable and high-risk populations, including infants and older adultsxample
Vaccine access, equity, and global policy
By highlighting the collaborations between researchers, biotech companies, and public health agencies, this series of articles will offer a snapshot of both current progress and prospects in respiratory viral vaccine innovation.
The benefit of publishing as part of an Article Collection is that they often become a key resource, driving a research community forward. This has a synergistic effect on every article in the Collection. The articles often receive more views and higher citation numbers as the Collections receive increased promotion via social media and our marketing team.
If you are interested in contributing to the Article Collection or want to learn more, then please reach out to the Commissioning Editor, Marya Baig, who will be happy to assist.
Submission information
Submission deadlines:
Standard track: April 14th, 2026
Accelerated Publication: June 14th, 2026
Accelerated Publication Plus: July 14th, 2026
Reasons to publish with us
Gain recognition from an international audience and increase your opportunities for future collaboration
Receive 50 free e-prints & promotional tips on promoting your article courtesy of our Author Services site
Immediately see the impact of your research made in the community by tracking downloads, citations, and the Altmetric Score of your article on My Authored Works
Increase the discoverability of your research with MEDLINE listings and more
Accelerated Publication
If time is critical in your publishing strategy, our Accelerated Publication options are available on a select number of biomedical journals and can help you get your research into a high-quality, peer-reviewed journal, fast.
Plain Language Summaries
When you are ready to submit your article, communicate the significance of your original research in a clear language to a broad audience using Plain Language Summary.
Open Access
Open access makes published academic research freely and permanently available so anyone, anywhere can read and build upon this research. We champion researcher choice with a variety of open access publishing options to meet the unique needs of each author.
Discover the Expert Collection
The Expert Collection is the world’s largest series of review journals in clinical medicine and R&D. Expert Collection articles present the personal opinions of our authors, all internationally recognized experts in their fields. They share their insights about where research is now, where it should go next, and how it should get there.
Editing Services
Pre-submission manuscript preparation can help you maximize the impact of your research and improve the quality of your manuscript. Services include English Language Editing, Scientific Editing, Manuscript formatting, and many more!